2Qiu C,Kivipelto M,von Strauss E.Epidemiology of Alzheimer's disease:occurrence,determinants,and strategies to ward intervention[J].Dialogues Clin Neurosci,2009;11(2):111-28.
3Golde TE.The Abeta hypothesis:leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease[J].Brain Pathol,2005;15(1):84-7.
4Shibata N,Kobayashi M.The role for oxidative stress in neurodegenerative disease[J].Brain Nerve,2008;60 (2):157-70.
5de la Torre JC.Pathphysiology of neuronal energy crisis in Alzheimer's disease[J].Neurodegener Dis,2008;5(3-4):126-32.
6Freir DB,Holscher C,Herron CE.Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo[J].J Neurophysiol,2001;85(2):708-13.
7Schmid AW,Freir DB,Herron CE.Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states[J].Brain Res,2008;1197:135-42.
8Hu Y,Russek SJ.BDNF and the diseased nervous system:a delicate balance between adaptive and pathological processes of gene regulation[J].J Neurochem,2008;105(1):1-17.
9Mattson MP,Maudsley S,Martin B.A neural signaling triumvirate that influences ageing and age-related disease:insulin/IGF-1,BDNF and serotonin[J].Aging Res.Rev,2004;3(4):445-64.
